VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,511,000 | -55.8% | 136,975 | -41.8% | 0.24% | -33.1% |
| Q4 2016 | $3,420,000 | +112.8% | 235,528 | +259.9% | 0.37% | +76.8% |
| Q3 2016 | $1,607,000 | -18.9% | 65,441 | -33.5% | 0.21% | -10.8% |
| Q2 2016 | $1,982,000 | +17.1% | 98,428 | +53.0% | 0.23% | -63.2% |
| Q1 2016 | $1,692,000 | +632.5% | 64,324 | +2736.2% | 0.63% | +473.6% |
| Q4 2015 | $231,000 | -91.3% | 2,268 | -84.8% | 0.11% | -84.9% |
| Q3 2015 | $2,660,000 | -20.7% | 14,910 | -11.7% | 0.73% | -39.5% |
| Q1 2015 | $3,354,000 | +1431.5% | 16,884 | +1002.1% | 1.20% | +947.8% |
| Q4 2014 | $219,000 | -66.8% | 1,532 | -69.4% | 0.12% | -46.3% |
| Q1 2014 | $660,000 | – | 5,008 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |